In the final part of this three-part series, Dr. Justin Abbatemarco and Dr. Jiwon Oh discuss how to address questions related to BTK Inhibitors with patients.
Show reference:
https://www.nejm.org/doi/full/10.1056/NEJMoa2415985
https://www.nejm.org/doi/full/10.1056/NEJMoa2415988
